Jon I Williams

Jon I Williams

UNVERIFIED PROFILE

Are you Jon I Williams?   Register this Author

Register author
Jon I Williams

Jon I Williams

Publications by authors named "Jon I Williams"

Are you Jon I Williams?   Register this Author

20Publications

275Reads

7Profile Views

Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children.

J Cataract Refract Surg 2020 Apr 21. Epub 2020 Apr 21.

From Clinical Affairs, Bausch + Lomb (Vittitow), Bridgewater, New Jersey, and Clinical Affairs, Bausch + Lomb (Williams), Irvine, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/j.jcrs.0000000000000218DOI Listing
April 2020

Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery.

J Cataract Refract Surg 2018 Oct 5;44(10):1220-1229. Epub 2018 Sep 5.

From the Manhattan Eye, Ear and Throat Hospital (Fong) and Lenox Hill Hospital (Fong), New York, New York, Shasta Eye Medical Group (Silverstein), Redding, United Medical Research Institute (Peace), Inglewood, Clinical Affairs, Bausch + Lomb (Williams), Irvine, California and Clinical Affairs, Bausch + Lomb (Vittitow), Bridgewater, New Jersey, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcrs.2018.06.056DOI Listing
October 2018

Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%.

Clin Ophthalmol 2014 13;8:1495-505. Epub 2014 Aug 13.

Ora, Inc., Andover, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OPTH.S66637DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140238PMC
August 2014

Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis.

Allergy Asthma Proc 2012 May-Jun;33(3):265-74

Eye Care Associates of Greater Cincinnati, Inc., Mason, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2500/aap.2012.33.3570DOI Listing
September 2012

Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.

J Ocul Pharmacol Ther 2011 Aug 7;27(4):385-93. Epub 2011 Jun 7.

ISTA Pharmaceuticals® Inc., Irvine, CA 92618-2301, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jop.2011.0005DOI Listing
August 2011

Apparent receptor-mediated activation of Ca2+-dependent conductive Cl- transport by shark-derived polyaminosterols.

Am J Physiol Regul Integr Comp Physiol 2005 Dec 18;289(6):R1644-58. Epub 2005 Aug 18.

Molecular and Vascular Medicine Unit, Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://www.physiology.org/doi/10.1152/ajpregu.00098.2005
Publisher Site
http://dx.doi.org/10.1152/ajpregu.00098.2005DOI Listing
December 2005

Regression of retinopathy by squalamine in a mouse model.

Pediatr Res 2004 Jul 5;56(1):144-9. Epub 2004 May 5.

Department of Pediatrics, Georgetown University, Wshington, DC 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1203/01.PDR.0000128977.55799.34DOI Listing
July 2004

Squalamine lactate reduces choroidal neovascularization in a laser-injury model in the rat.

Retina 2003 Dec;23(6):808-14

Retina Service Research Laboratories, Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/retinajournal/2003/12000/Squala
Web Search
http://dx.doi.org/10.1097/00006982-200312000-00011DOI Listing
December 2003

A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.

Clin Cancer Res 2003 Sep;9(11):4108-15

Department of Thoracic/Head and Neck Medical Oncology and Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
September 2003

A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor.

Clin Cancer Res 2003 Jul;9(7):2465-71

Institute for Drug Development, Cancer Therapy and Research Center and The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA.

View Article

Download full-text PDF

Source
July 2003

Effect of squalamine on iris neovascularization in monkeys.

Retina 2002 Dec;22(6):772-8

Department of Ophthalmology, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, LA 70112-2699, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00006982-200212000-00014DOI Listing
December 2002

Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.

Oncogene 2002 Apr;21(18):2805-14

UCLA School of Medicine, Department of Medicine, Division of Hematology-Oncology and Jonsson Comprehensive Cancer Center, Los Angeles, California, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205410DOI Listing
April 2002